KALA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.3 USD | +1.94% |
|
-4.40% | -10.00% |
| 02/04 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
| 29/03 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar KALA BIO, Inc.
c646227.Jjmhkqipax8h7TO21e4pWqsNma6pMNV0eFST5UhNC2E.UAz00_rlPlwRq0GFttlnbdNe_drPBq8BQGPciiIoUglKCcnDwc0fa3SXdg~09be9e767eb37530d056933e727db392
Upcoming events on KALA BIO, Inc.
Past events on KALA BIO, Inc.
| 29/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 04/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 13/02/2024 10:30 pm | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
| 13/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 17/08/2023 10:30 pm | Sidoti Micro Cap Conference |
| 16/08/2023 04:30 pm | H.C. Wainwright Ophthalmology Virtual Conference |
| 09/08/2023 | Wedbush PacGrow Healthcare Conference |
| 04/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 22/06/2023 08:30 pm | Annual General Meeting |
| 09/06/2023 09:25 pm | Jefferies Global Healthcare Conference |
| 09/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 24/04/2023 08:30 pm | Extraordinary Shareholders Meeting |
| 15/03/2023 09:30 pm | Oppenheimer Healthcare Conference - Fireside Chat |
| 03/03/2023 06:30 pm | Q4 2022 Earnings Release |
| 08/11/2022 06:30 pm | Q3 2022 Earnings Release |
| 19/10/2022 08:30 pm | Extraordinary Shareholders Meeting |
| 12/09/2022 04:30 pm | H.C. Wainwright Global Investment Conference |
| 17/08/2022 04:30 pm | H.C. Wainwright Ophthalmology Virtual Conference |
| 11/08/2022 05:30 pm | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,07 7,73 -21.45% | 6,36 6,55 -2.84% | 11,2 12,5 -10.23% | 3,89 3,76 3.47% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -77,4 -86,6 10.62% | -82,0 -94,3 13.04% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -88,2 -86,8 -1.69% | -96,2 -90,9 -5.81% | -130 -106 -23.39% | -81,7 -80,8 -1.17% | -39,7 -40,4 1.73% | -41,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,3 -92,3 -2.21% | -104 -97,0 -7.54% | -143 -117 -21.59% | -44,8 -65,7 31.78% | -42,2 -43,2 2.31% | -40,2 |
|
Net income Million USD | Released Forecast Spread | -94,3 -92,3 -2.21% | -104 -97,1 -7.46% | -143 -117 -21.51% | -44,8 -65,7 31.78% | -42,2 -43,2 2.31% | -40,2 |
|
EPS USD | Released Forecast Spread | -138 -135 -2.07% | -99,5 -92,0 -8.13% | -110 -88,1 -24.26% | -29,5 -23,8 -23.63% | -17,4 -18,0 3.79% | -10,2 |
| Announcement Date | 12/02/20 | 25/02/21 | 29/03/22 | 03/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,86 3,41 -45.51% | 1,37 2,88 -52.43% | 2,10 2,02 3.87% | 0,42 41,7 -98.99% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,83 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -46,8 -26,4 -77.57% | -30,9 -23,0 -34.18% | -26,0 -29,2 11.14% | -14,6 16,9 -186.25% | -10,3 -9,31 -10.12% | -11,7 -8,74 -33.73% | -9,60 -10,2 6.26% | -8,76 -8,71 -0.59% | -9,62 -10,3 6.78% | -9,90 | -9,90 | -10,9 | -10,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -47,6 -27,1 -75.8% | -32,9 -25,1 -31.33% | -28,1 -31,8 11.46% | 29,1 15,5 87.51% | -12,8 -10,2 -25.55% | -14,5 -9,88 -46.38% | -10,4 -6,13 -70.01% | -8,70 -4,49 -93.75% | -8,63 -9,63 10.37% | -9,38 | -9,41 | -10,4 | -10,5 |
|
Net income Million USD | Released Forecast Spread | -47,6 -27,1 -75.8% | -32,9 -25,1 -31.33% | -28,1 -31,8 11.46% | 29,1 15,5 87.51% | -12,8 -10,2 -25.55% | -14,5 -9,88 -46.38% | -10,4 -6,13 -70.01% | -8,70 -4,49 -93.75% | -8,63 -9,63 10.37% | -9,38 | -9,41 | -10,4 | -10,5 |
|
EPS USD | Released Forecast Spread | -34,0 -19,5 -74.36% | -22,5 -17,2 -31.18% | -19,0 -21,8 12.64% | 19,3 10,8 79.07% | -7,97 -6,56 -21.59% | -6,99 -5,10 -37.06% | -4,36 -3,19 -36.82% | -3,41 -2,15 -58.36% | -2,99 -3,62 17.4% | -2,89 | -2,86 | -3,10 | -1,87 |
| Announcement Date | 29/03/22 | 16/05/22 | 11/08/22 | 08/11/22 | 03/03/23 | 09/05/23 | 04/08/23 | 13/11/23 | 29/03/24 | - | - | - | - |
More events
Past sector events for KALA BIO, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KALA Stock
- Calendar KALA BIO, Inc.
